Search Results - "Belda-Iniesta C"

This result is not displayed to guests.
Login for full access.

New insights in β-tubulin sequence analysis in non-small cell lung cancer

Authors: de Castro, J. Belda-Iniesta, C. Cejas, P. et al.

Source: Lung Cancer (01695002). Jul2003, Vol. 41 Issue 1, p41. 8p.

Do β-tubulin pseudogenes really matter?

Authors: Belda-Iniesta C, Cristobal Perona, Rosario de Castro Carpeno, Javier et al.

Source: Lancet Oncology. May2004, Vol. 5 Issue 5, p271. 2p.

PCN88 Cost-Effectiveness Analysis Per Life-Year Gained Based on Predictors of Response for First Line Metastasic Colorectal Cancer Therapy in Spain

Authors: Belda-Iniesta, C. Moreno, V. Martínez-Amores, B. et al.

Source: Value in Health. Nov2012, Vol. 15 Issue 7, pA425-A425. 1p.

Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma.

Authors: García-Romero, N. Palacín-Aliana, I. Madurga, R. et al.

Source: BMC Medicine. 6/22/2020, Vol. 18 Issue 1, p1-16. 16p. 2 Diagrams, 1 Chart, 4 Graphs.

Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study.

Authors: Ramirez de Molina A Sarmentero-Estrada J Belda-Iniesta C et al.

Source: Lancet Oncology. Oct2007, Vol. 8 Issue 10, p889-897. 9p.

IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer.

Authors: Cortés-Sempere, M de Miguel, M P Pernía, O et al.

Source: Oncogene. 3/7/2013, Vol. 32 Issue 10, p1274-1283. 10p. 1 Color Photograph, 1 Black and White Photograph, 1 Diagram, 3 Graphs.

DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer.

Authors: Moncho-Amor, V Ibañez de Cáceres, I Bandres, E et al.

Source: Oncogene. 2/10/2011, Vol. 30 Issue 6, p668-678. 11p.

IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.

Authors: Ibanez de Caceres, I. Cortes-Sempere, M. Moratilla, C. et al.

Source: Oncogene. 3/18/2010, Vol. 29 Issue 11, p1681-1690. 10p. 1 Diagram, 1 Chart, 4 Graphs.

A critical role for choline kinase-α in the aggressiveness of bladder carcinomas.

Authors: Hernando, E. Sarmentero-Estrada, J. Koppie, T. et al.

Source: Oncogene. 7/2/2009, Vol. 28 Issue 26, p2425-2435. 11p. 2 Charts, 4 Graphs.

MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.

Authors: Chattopadhyay, S. Machado-Pinilla, R. Manguan-García, C. et al.

Source: Oncogene. 6/1/2006, Vol. 25 Issue 23, p3335-3345. 11p. 2 Diagrams, 2 Charts, 6 Graphs.

Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer.

Authors: Feliu, J. Borrega, P. León, A. et al.

Source: Cancer Chemotherapy & Pharmacology. Jan2011, Vol. 67 Issue 1, p215-221. 7p.

Checkpoint kinase 1 modulates sensitivity to cisplatin after spindle checkpoint activation in SW620 cells

Authors: Peralta-Sastre, A. Manguan-Garcia, C. de Luis, A. et al.

Source: International Journal of Biochemistry & Cell Biology. Feb2010, Vol. 42 Issue 2, p318-328. 11p.

MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.

Authors: Cortes-Sempere M Chattopadhyay S Rovira A et al.

Source: Cancer Letters. Dec2009, Vol. 286 Issue 2, p206-216. 11p.

Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy.

Authors: García, V. Moreno Cejas, P. Codesido, M. Blanco et al.

Source: International Journal of Colorectal Disease. Jul2009, Vol. 24 Issue 7, p741-748. 8p. 5 Charts, 2 Graphs.

Polyethylene glycol improves current methods for circulating extracellular vesicle-derived DNA isolation.

Authors: García-Romero, N Madurga, R Rackov, G et al.

Source: Journal of Translational Medicine. 3/11/2019, Vol. 17 Issue 1, p75-75. 1p.

Efficacy and Safety Results From a Phase 2, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy in Advanced Squamous-Cell Non-Small Cell Lung Cancer (sq NSCLC): Metastatic Non-Small Cell Lung Cancer.

Authors: Hirsch, F.R. Govindan, R. Zvirbule, Z. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2014 Supplement, Vol. 90 Issue 5, pS37-S37. 1p.

EP-1385: Hypofraccionated stereotactic reirradiation with Novalis linac in patients with high-grade gliomas.

Authors: Lopez Gonzalez, M. Hernando Requejo, O. Sanchez Saugar, E. et al.

Source: Radiotherapy & Oncology. 2014 Supplement, Vol. 111, pS116-S117. 1p.

PCN71 Cost-Effectiveness Analysis of Cetuximab and Panitumumab as First-Line Therapies for Metastatic Colorectal Cancer in Spain

Authors: Moreno, V. Martínez-Amores, B. Barriuso, J. et al.

Source: Value in Health. Nov2012, Vol. 15 Issue 7, pA421-A422. 0p.

PCN40 Year to Year Budget Impact Analysis of Biological Therapies for First-Line Treatment of Metastatic Colorectal Cancer in Spain

Authors: Martínez-Amores, B. Mezquita, L. Ibáñez de Cáceres, I. et al.

Source: Value in Health. Nov2012, Vol. 15 Issue 7, pA416-A416. 1p.